Rights and permissions
About this article
Cite this article
IV immunoglobulin (IVIG) is a valid maintenance therapy option for myasthenia gravis. Inpharma Wkly. 1299, 12 (2001). https://doi.org/10.2165/00128413-200112990-00031
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200112990-00031